Parametrica Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Parametrica Management’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-65,098	Closed	-$11K	–	35
2023 Q1	$11K	Hold	65,098	–	–	0.02%	26
2022 Q4	$25.9K	Hold	65,098	–	–	0.05%	44
2022 Q3	$51K	Sell	65,098 -4,486	-6%	-$9.42K	0.1%	59
2022 Q2	$200K	Hold	69,584	–	–	0.22%	129
2022 Q1	$436K	Hold	69,584	–	–	0.32%	63
2021 Q4	$775K	Hold	69,584	–	–	0.77%	33
2021 Q3	$1.14M	Hold	69,584	–	–	0.85%	33
2021 Q2	$1.29M	Buy	+69,584	New	+$1.34M	0.95%	35

Parametrica Management's CDAK Position: Q2 2023 in Review

Parametrica Management sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 65,098 shares — an estimated $11K sold.

Parametrica Management first reported a position in CDAK in Q2 2021 and held it in 8 quarters. The position peaked at $1.29M in Q2 2021. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

Parametrica Management reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Parametrica Management sold 65,098 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $11K.
Parametrica Management first reported a position in Codiak BioSciences, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Parametrica Management's Codiak BioSciences, Inc. Common Stock position peaked at $1.29M in Q2 2021.
1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on Parametrica Management's 13F filing for Q2 2023, filed 3 Aug 2023.